Literature DB >> 32894346

Kono-S anastomosis for Crohn's disease: a systemic review, meta-analysis, and meta-regression.

Cheng Han Ng1, Yip Han Chin1, Snow Yunni Lin1, Jeffery Wei Heng Koh2, Bettina Lieske1,3, Frederick Hong-Xiang Koh4, Choon Seng Chong5,6, Fung Joon Foo4.   

Abstract

The Kono-S anastomosis was introduced in 2011 as an alternative anastomosis in Crohn's disease (CD) surgery. Since then, prevailing evidence of the favorable results of the Kono-S anastomosis has been published from around the world. We conducted this study to analyze the effectiveness of the Kono-S anastomosis, by searching Medline, Embase, CNKI, and google scholar. Binominal data were analyzed after Freeman-Tukey double-arcsine transformation. Comparative data were analyzed using the Mantel-Haenszel model for dichotomous outcomes and the mean difference for continuous outcomes. We identified 676 patients who underwent surgery with a Kono-S anastomosis. Surgical recurrence was pooled at an average of 0% (CI: 0.00-0.01) and a reduced mean Rutgeerts score of 1.375 (CI: 0.727-2.023) after Kono-S anastomosis. Endoscopic recurrence after sensitivity analysis was 5% (CI: 0.00-0.15). Complications were rare, with a 3% incidence of ileus (CI: 0.01-0.05), a 4% incidence of small bowel obstruction (CI: 0.01-0.10), a 1% incidence of an anastomotic leak incidence (CI: 0.00-0.03), and a 10% incidence of postoperative infection (CI: 0.03-0.20). Evidence from this meta-analysis favors the Kono-S anastomosis for CD patients, especially for ileocolic anastomosis. Thus, clinicians should consider the applicability of Kono-S anastomosis in respective institutions.

Entities:  

Keywords:  Crohn’s disease; End-to-end anastomosis; Kono-S; Meta-analysis

Year:  2020        PMID: 32894346     DOI: 10.1007/s00595-020-02130-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  26 in total

1.  Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Br J Surg       Date:  2000-12       Impact factor: 6.939

2.  Infliximab prevents Crohn's disease recurrence after ileal resection.

Authors:  Miguel Regueiro; Wolfgang Schraut; Leonard Baidoo; Kevin E Kip; Antonia R Sepulveda; Marilyn Pesci; Janet Harrison; Scott E Plevy
Journal:  Gastroenterology       Date:  2008-10-31       Impact factor: 22.682

3.  Predictability of the postoperative course of Crohn's disease.

Authors:  P Rutgeerts; K Geboes; G Vantrappen; J Beyls; R Kerremans; M Hiele
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

Review 4.  Is "functional end-to-end anastomosis" really functional? A review of the literature on stapled anastomosis using linear staplers.

Authors:  Masayuki Kano; Naoyuki Hanari; Hisashi Gunji; Koichi Hayano; Hideki Hayashi; Hisahiro Matsubara
Journal:  Surg Today       Date:  2016-03-17       Impact factor: 2.549

5.  A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease.

Authors:  Toru Kono; Toshifumi Ashida; Yoshiaki Ebisawa; Naoyuki Chisato; Kotaro Okamoto; Hidetoshi Katsuno; Kotaro Maeda; Mikihiro Fujiya; Yutaka Kohgo; Hiroyuki Furukawa
Journal:  Dis Colon Rectum       Date:  2011-05       Impact factor: 4.585

6.  Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.

Authors:  J Cosnes; I Nion-Larmurier; L Beaugerie; P Afchain; E Tiret; J-P Gendre
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

7.  Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?

Authors:  Nozomi Takeshima; Takashi Sozu; Aran Tajika; Yusuke Ogawa; Yu Hayasaka; Toshiaki A Furukawa
Journal:  BMC Med Res Methodol       Date:  2014-02-21       Impact factor: 4.615

8.  Metaprop: a Stata command to perform meta-analysis of binomial data.

Authors:  Victoria N Nyaga; Marc Arbyn; Marc Aerts
Journal:  Arch Public Health       Date:  2014-11-10

9.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.

Authors:  Xiang Wan; Wenqian Wang; Jiming Liu; Tiejun Tong
Journal:  BMC Med Res Methodol       Date:  2014-12-19       Impact factor: 4.615

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  4 in total

Review 1.  [Terminal ileitis in Crohn's disease-Is primary surgery the better treatment?]

Authors:  S Flemming; M Kim; C-T Germer
Journal:  Chirurg       Date:  2021-01       Impact factor: 0.955

Review 2.  Aspects Towards the Anastomotic Healing in Crohn's Disease: Clinical Approach and Current Gaps in Research.

Authors:  F H M Chaim; L M V Negreiros; K M Steigleder; N S N Siqueira; L M Genaro; P S P Oliveira; C A R Martinez; M L S Ayrizono; J J Fagundes; R F Leal
Journal:  Front Surg       Date:  2022-06-24

Review 3.  Essential updates 2020/2021: Colorectal diseases (benign)-Current topics in the surgical and medical treatment of benign colorectal diseases.

Authors:  Hiroshi Sawayama; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2022-01-25

Review 4.  Surgical Strategies to Reduce Postoperative Recurrence of Crohn's Disease After Ileocolic Resection.

Authors:  Ian S Reynolds; Katie L Doogan; Éanna J Ryan; Daniel Hechtl; Frederik P Lecot; Shobhit Arya; Sean T Martin
Journal:  Front Surg       Date:  2021-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.